ATF4 and retinal degeneration: Using C57Bl/6 mice, it was shown that ATF4 single-knockdown (ATF4+/−) of T17M was sufficient to yield a therapeutic response by significantly delaying retinal degeneration, whereas double-knockdowns enhanced the observed effect [122].